Sara Arce‐Gallego

414 total citations
5 papers, 43 citations indexed

About

Sara Arce‐Gallego is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sara Arce‐Gallego has authored 5 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sara Arce‐Gallego's work include PARP inhibition in cancer therapy (3 papers), Prostate Cancer Treatment and Research (2 papers) and Advanced Breast Cancer Therapies (1 paper). Sara Arce‐Gallego is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), Prostate Cancer Treatment and Research (2 papers) and Advanced Breast Cancer Therapies (1 paper). Sara Arce‐Gallego collaborates with scholars based in Spain, United States and Palestinian Territory. Sara Arce‐Gallego's co-authors include Rafael Morales‐Barrera, Joaquı́n Mateo, Anna Bigas, Yolanda Guillén, Laura Marruecos, Alejandro Athie, Cristina Suárez, Joan Bertran, Joan Carles and Lluı́s Espinosa and has published in prestigious journals such as Journal of Clinical Oncology, EMBO Reports and Molecular Cancer Therapeutics.

In The Last Decade

Sara Arce‐Gallego

5 papers receiving 43 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Arce‐Gallego Spain	3	26	17	15	14	9	5	43
Camilla Borges Ferreira Gomes United States	5	39 1.5×	21 1.2×	18 1.2×	13 0.9×	7 0.8×	5	70
Zhenkun Zhuang China	4	43 1.7×	21 1.2×	18 1.2×	13 0.9×	15 1.7×	13	76
Sidwell Rigade France	2	32 1.2×	11 0.6×	11 0.7×	8 0.6×	7 0.8×	2	56
Geoffrey Fell United States	4	22 0.8×	20 1.2×	21 1.4×	14 1.0×	6 0.7×	10	70
Jill D. Kremer United States	5	30 1.2×	24 1.4×	14 0.9×	15 1.1×	5 0.6×	11	58
Ylva Paulsson-Karlsson Sweden	7	49 1.9×	16 0.9×	8 0.5×	18 1.3×	11 1.2×	8	85
Annette Kolodzie United States	4	17 0.7×	35 2.1×	22 1.5×	20 1.4×	5 0.6×	6	58
Peony Hiu Yan Poon Hong Kong	3	31 1.2×	26 1.5×	18 1.2×	16 1.1×	8 0.9×	5	55
Jakob Sidenius Johansen Denmark	4	19 0.7×	14 0.8×	18 1.2×	12 0.9×	3 0.3×	10	43
Swapnil Parmar United States	5	20 0.8×	43 2.5×	22 1.5×	30 2.1×	5 0.6×	10	72

Countries citing papers authored by Sara Arce‐Gallego

Since Specialization

Citations

This map shows the geographic impact of Sara Arce‐Gallego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Arce‐Gallego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Arce‐Gallego more than expected).

Fields of papers citing papers by Sara Arce‐Gallego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Arce‐Gallego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Arce‐Gallego. The network helps show where Sara Arce‐Gallego may publish in the future.

Co-authorship network of co-authors of Sara Arce‐Gallego

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Arce‐Gallego. A scholar is included among the top collaborators of Sara Arce‐Gallego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Arce‐Gallego. Sara Arce‐Gallego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Aguilar, Daniel, Sara Arce‐Gallego, Irene Casanova‐Salas, et al.. (2025). Harnessing Senolytics and PARP Inhibition to Expand the Antitumor Activity of CDK4/6 Inhibitors in Prostate Cancer. Molecular Cancer Therapeutics. 24(12). 1959–1976. 1 indexed citations

2.

Llop‐Guevara, Alba, Sara Arce‐Gallego, Mafalda Oliveira, et al.. (2022). Identification of homologous recombination deficiency (HRD) by RAD51 in a tumor molecular profiling program for precision medicine.. Journal of Clinical Oncology. 40(16_suppl). 3137–3137. 1 indexed citations

3.

Marruecos, Laura, Joan Bertran, María Carmen Mulero, et al.. (2021). Dynamic chromatin association of IκBα is regulated by acetylation and cleavage of histone H4. EMBO Reports. 22(8). e52649–e52649. 11 indexed citations

4.

Marruecos, Laura, Joan Bertran, Yolanda Guillén, et al.. (2020). IκBα deficiency imposes a fetal phenotype to intestinal stem cells. EMBO Reports. 21(6). e49708–e49708. 14 indexed citations

5.

Athie, Alejandro, Sara Arce‐Gallego, Rafael Morales‐Barrera, et al.. (2019). Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer. Current Oncology Reports. 21(5). 42–42. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact